← Back to All Filings

Vanguard Group Reports 0% Stake in Labcorp Following Internal Realignment

Low SignificanceMarch 26, 2026 at 11:47:29 AM EDT

LABCORP HOLDINGS INC.

$LHSCHEDULE 13G/ACIK: 0000920148

Subscribe to track LH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Group Reports 0% Stake in Labcorp Following Internal Realignment

Company: Labcorp Holdings Inc (CIK: 0000920148) Form: SCHEDULE 13G/A | Filed: 2026/03/26 Significance: Low (Administrative)

Investor: The Vanguard Group Type: Institutional Investor

Filing Details: • Previous Stake: >5% (Implied by Amendment #14) • Current Stake: 0 shares (0.0%) • Reason: Internal corporate realignment

Key Insight: This is likely not a market sell-off. Vanguard notes that subsidiaries will now report beneficial ownership separately. The parent company (Vanguard Group Inc.) is disaggregating its reporting structure.

Market Context: Labcorp has a Market Cap of $21.67B. This filing represents a change in reporting compliance rather than a change in investment sentiment.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Labcorp Holdings Inc

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Vanguard Group Inc. reports 0% ownership due to an internal administrative realignment, not a liquidation of assets.
  • Market Impact: Neutral. The underlying funds likely still hold the assets, but the reporting entity structure has changed.

Company Information

FieldValue
CompanyLabcorp Holdings Inc
CIK0000920148
IndustryMedical Laboratories
Market Cap$21.67 Billion

Investor Information

FieldValue
NameThe Vanguard Group
CIK0000102909
TypeInvestment Adviser
LocationMalvern, PA

Filing Details

FieldValue
Form TypeSCHEDULE 13G/A (Amendment 14)
Event Date03/13/2026
Shares Beneficially Owned0
Percent of Class0%
Ownership TypeN/A

Financial Impact Assessment

Transaction Materiality

  • Reported Ownership Change: The filing shows a reduction to 0 shares.
  • Context: This is Amendment #14, indicating a long-standing previous position (typically Vanguard holds 5-10% of major indices).
  • Materiality Assessment: Low. While the number change is massive, the cause is administrative.

Impact Evaluation

  • Market Cap Context: For a $21.67B company, a complete exit by Vanguard would be a market-moving event. However, the footnotes clarify this is not an exit.
  • Footnote Analysis: "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately... The Vanguard Group, Inc. no longer has... beneficial ownership."

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing explicitly states that subsidiaries pursue the same investment strategies as before. The shares have likely moved from being reported by the parent "Vanguard Group Inc" to individual funds or subsidiary entities.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Investment Insights

Key Takeaways

  1. Administrative Change: This filing is a technicality regarding how Vanguard aggregates its holdings for SEC reporting.
  2. No Bearish Signal: Investors should not interpret this as Vanguard losing faith in Labcorp.
  3. Future Filings: Expect to see new 13G filings from Vanguard subsidiaries or specific funds replacing this aggregate report.

Note: This analysis focuses on the structural nature of the filing. No open-market transaction occurred.

Topics:#SECFiling#Labcorp#Vanguard#Form13G#InstitutionalOwnership#MarketNews#FinancialEducation

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.